Global Oncology Molecular Diagnostics Market 2015-2019 is the latest addition to Sandlerresearch.org industry research reports collection. The analysts forecast global oncology molecular diagnostics market to grow at a CAGR of 17.8% over the period 2014-2019. Read this 63 Pages report on Global Oncology Molecular Diagnostics Market 2015-2019; the report provides 29 Exhibits. Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen typing. Oncology molecular diagnostics is a major application of molecular biology and is increasingly used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major that are diagnosed and treated by molecular diagnostics are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung, and endometrial cancers. Covered in this report This report covers the current scenario and the growth prospects of the global oncology molecular diagnostics market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of diagnostics assay kits and instruments for cancers, which include:
Breast Colorectal Prostate Others (including lung and cervical cancers)
The report, Global Oncology Molecular Diagnostics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Purchase a Report Copy at http://www.sandlerresearch.org/purchase?rname=42583 . Alternatively get Discount on the Report at http://www.sandlerresearch.org/discount?rname=42583 . Single User License: US $2500 Special Offer on Technavio/Infiniti Reports Buy 3 reports at the Cost of 2 (Lowest Priced Report will be free)/ Buy 3 Reports of the Same Price for the Cost of 2. Buy 4 or more Reports and get 50% flat discount on the total price. [IMP Note: This Offer Only Valid Via Email To sales@sandlerresearch.org OR Call +1-888-391-5441]
Key regions
APAC Europe Latin America MEA North America
Key vendors
Abbott Diagnostics Becton, Dickinson and Company QIAGEN Roche Diagnostics
Other prominent vendors
Agendia Angsana Molecular and Diagnostics Asuragen Autogenomics Beckman Coulter bioMérieux bioTheranostics (Formerly AviaraDx) Cangen Biotechnologies Cepheid Diagnocure Epigenomics Eragen EXACT Sciences Exiqon GeneNews Genera Biosystems Genomic Health Genomix Biotech Health Discovery HTG Molecular Hologic Innogenetics Intergenetics Kreatech Holding Myriad Genetics Nanosphere NorDiag Nuvera Biosciences OncoMethylome Sciences Orion Genomics
Prediction Sciences Predictive Biosciences Rosetta Genomics SensiGen Source MDx Vermillion Inquire before Buying at http://www.sandlerresearch.org/inquire-before-buying?rname=42583 . Market driver
Increase in demand for personalized medicines
Market challenge
Ethical, privacy, and practical issues
Market trend
Advances in mass spectrometry
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? List of Exhibits: Exhibit 01: Product offerings Exhibit 02: Snapshot of global oncology molecular diagnostics market 2015-2019 Exhibit 03: Prevalent cancers worldwide 2012 Exhibit 04: Countries with highest cancer rates 2012 Exhibit 05: Cancer by gender 2012 Exhibit 06: Global oncology molecular diagnostics market 2014-2019 ($ billions) Exhibit 07: Five forces analysis Exhibit 08: Reimbursement perspectives of healthcare entities Exhibit 09: Factors influencing price of molecular diagnostic products
Exhibit 10: Global oncology molecular diagnostics market segmentation by cancer type Exhibit 11: Global oncology molecular diagnostics market segmentation by cancer type 2014 Exhibit 12: Global oncology molecular diagnostics market by cancer type 2014 ($ millions) Exhibit 13: Global oncology molecular diagnostics market segmentation by geography 2014 Exhibit 14: Global oncology molecular diagnostics market segmentation by geography 2019 Exhibit 15: Global oncology molecular diagnostics market by geography 2014-2019 Exhibit 16: Oncology molecular diagnostics market in Americas 2014-2019 ($ millions) Exhibit 17: Oncology molecular diagnostics market in EMEA 2014-2019 ($ millions) Exhibit 18: Oncology molecular diagnostics market in APAC 2014-2019 ($ millions) Exhibit 19: Impact of drivers Exhibit 20: Impact of drivers and challenges Exhibit 21: Abbott: Key takeaways Exhibit 22: Becton, Dickinson: Key takeaways Exhibit 23: Qiagen: Key takeaways Exhibit 24: Roche Diagnostics: Key takeaways Exhibit 25: Abbott Diagnostics: Key business offerings Exhibit 26: Becton, Dickinson: Business segmentation by revenue 2014 Exhibit 27: Becton, Dickinson: Business segmentation by revenue 2013 and 2014 ($ billions) Exhibit 28: Becton, Dickinson: Geographical segmentation by revenue 2014 Exhibit 29: Segmentation of Qiagen's business by revenues 2014 Browse Other Reports on Pharmaceutical, Pharmaceuticals and Healthcare . Contact sales@sandlerresearch.org / Call +1 888 391 5441 for further information on “Global Oncology Molecular Diagnostics Market 2015-2019� report OR for any other market research and intelligence needs you may have for your business. About Us:
Sandlerresearch.org is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business. NOTE: This Report Is NOT Free Of Charge.